Last week, IDL Diagnostics participated in the Sweden-Indonesia Sustainability Partnership (SISP) 2025, organized by Business Sweden and the Swedish Embassy in Indonesia.
The Sweden-Indonesia Sustainability Partnership (SISP) is a platform designed to foster government collaboration and business partnerships in support of the Sustainable Development Goals, for more information see Sweden-Indonesia Sustainability Partnership – Sweden Abroad
We visited both public and private hospitals, including institutions such as Dharmais National Cancer Hospital, Cipto Mangunkusumo National Central Teaching Hospital, and the Siloam Hospital Group, showcasing a diverse range of healthcare settings and practices. Several health agencies and organizations from outside Jakarta also participated in the conference, contributing valuable regional perspectives and expertise.
Other highlights of the programme included a cancer symposium, high-level meetings, and many other promising opportunities to grow both existing and new business.
Key participants included Swedish Health Minister Acko Ankarberg Johansson, Indonesian Health Minister Budi Gunadi Sadikin, Deputy Health Minister Dante Saksono Harbuwono, and representatives from Swedish companies such as AstraZeneca, Getinge, HemoCue, Elekta, Essity, and IDL Diagnostics.
IDL Diagnostics has a long history of working in the Indonesian health sector and sees this as an important step toward further strengthening our position in the market, in collaboration with other Swedish and local partners.
